Literature DB >> 23649625

Identification of a secondary promoter within the human B cell receptor component gene hCD79b.

Eung Jae Yoo1, Nancy E Cooke, Stephen A Liebhaber.   

Abstract

The human B cell-specific protein, CD79b (also known as Igβ and B29) constitutes an essential signal transduction component of the B cell receptor. Although its function is central to the triggering of B cell terminal differentiation in response to antigen stimulation, the transcriptional determinants that control CD79b gene expression remain poorly defined. In the present study, we explored these determinants using a series of hCD79b transgenic mouse models. Remarkably, we observed that the previously described hCD79b promoter along with its associated enhancer elements and first exon could be deleted without appreciable loss of hCD79b transcriptional activity or tissue specificity. In this deletion setting, a secondary promoter located within exon 2 maintained full levels and specificity of hCD79b transcription. Of note, this secondary promoter was also active, albeit at lower levels, in the wild-type hCD79b locus. The activity of the secondary promoter was dependent on the action(s) of a conserved sequence element mapping to a chromatin DNase I hypersensitive site located within intron 1. mRNA generated from this secondary promoter is predicted to encode an Igβ protein lacking a signal sequence and thus unable to serve normal B cell receptor function. Although the physiologic role of the hCD79b secondary promoter and its encoded protein remain unclear, the current data suggest that it has the capacity to play a role in normal as well as pathologic states in B cell proliferation and function.

Entities:  

Keywords:  B Cell; DNase I Hypersensitive Site; Gene Expression; Immunology; Secondary Promoter; Transcription Enhancers; Transcription Promoter; Transgenic Mice; hCD79b

Mesh:

Substances:

Year:  2013        PMID: 23649625      PMCID: PMC3689977          DOI: 10.1074/jbc.M113.461988

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

Review 1.  The ETS-domain transcription factor family.

Authors:  A D Sharrocks
Journal:  Nat Rev Mol Cell Biol       Date:  2001-11       Impact factor: 94.444

2.  Cutting edge: a hypomorphic mutation in Igbeta (CD79b) in a patient with immunodeficiency and a leaky defect in B cell development.

Authors:  A Kerry Dobbs; Tianyu Yang; Dana Farmer; Leo Kager; Ornella Parolini; Mary Ellen Conley
Journal:  J Immunol       Date:  2007-08-15       Impact factor: 5.422

3.  An RNA-independent linkage of noncoding transcription to long-range enhancer function.

Authors:  Eung Jae Yoo; Nancy E Cooke; Stephen A Liebhaber
Journal:  Mol Cell Biol       Date:  2012-03-19       Impact factor: 4.272

4.  Pit-1 binding sites at the somatotrope-specific DNase I hypersensitive sites I, II of the human growth hormone locus control region are essential for in vivo hGH-N gene activation.

Authors:  B M Shewchuk; S L Asa; N E Cooke; S A Liebhaber
Journal:  J Biol Chem       Date:  1999-12-10       Impact factor: 5.157

5.  Downregulation of the B-cell receptor signaling component CD79b in plasma cell myeloma: a possible post transcriptional regulation.

Authors:  Xingang Huang; Katsuyoshi Takata; Yasuharu Sato; Takehiro Tanaka; Kouichi Ichimura; Maiko Tamura; Takashi Oka; Tadashi Yoshino
Journal:  Pathol Int       Date:  2011-01-11       Impact factor: 2.534

6.  Epigenetic activation of the human growth hormone gene cluster during placental cytotrophoblast differentiation.

Authors:  Atsushi P Kimura; Daria Sizova; Stuart Handwerger; Nancy E Cooke; Stephen A Liebhaber
Journal:  Mol Cell Biol       Date:  2007-07-16       Impact factor: 4.272

7.  Differential DNase I hypersensitivity reveals factor-dependent chromatin dynamics.

Authors:  Housheng Hansen He; Clifford A Meyer; Mei Wei Chen; V Craig Jordan; Myles Brown; X Shirley Liu
Journal:  Genome Res       Date:  2012-04-16       Impact factor: 9.043

8.  Characterization of transcription from TATA-less promoters: identification of a new core promoter element XCPE2 and analysis of factor requirements.

Authors:  Ramakrishnan Anish; Mohammad B Hossain; Raymond H Jacobson; Shinako Takada
Journal:  PLoS One       Date:  2009-04-01       Impact factor: 3.240

9.  Mutations of the Igbeta gene cause agammaglobulinemia in man.

Authors:  Simona Ferrari; Vassilios Lougaris; Stefano Caraffi; Roberta Zuntini; Jianying Yang; Annarosa Soresina; Antonella Meini; Giantonio Cazzola; Cesare Rossi; Michael Reth; Alessandro Plebani
Journal:  J Exp Med       Date:  2007-08-20       Impact factor: 14.307

10.  The accessible chromatin landscape of the human genome.

Authors:  Robert E Thurman; Eric Rynes; Richard Humbert; Jeff Vierstra; Matthew T Maurano; Eric Haugen; Nathan C Sheffield; Andrew B Stergachis; Hao Wang; Benjamin Vernot; Kavita Garg; Sam John; Richard Sandstrom; Daniel Bates; Lisa Boatman; Theresa K Canfield; Morgan Diegel; Douglas Dunn; Abigail K Ebersol; Tristan Frum; Erika Giste; Audra K Johnson; Ericka M Johnson; Tanya Kutyavin; Bryan Lajoie; Bum-Kyu Lee; Kristen Lee; Darin London; Dimitra Lotakis; Shane Neph; Fidencio Neri; Eric D Nguyen; Hongzhu Qu; Alex P Reynolds; Vaughn Roach; Alexias Safi; Minerva E Sanchez; Amartya Sanyal; Anthony Shafer; Jeremy M Simon; Lingyun Song; Shinny Vong; Molly Weaver; Yongqi Yan; Zhancheng Zhang; Zhuzhu Zhang; Boris Lenhard; Muneesh Tewari; Michael O Dorschner; R Scott Hansen; Patrick A Navas; George Stamatoyannopoulos; Vishwanath R Iyer; Jason D Lieb; Shamil R Sunyaev; Joshua M Akey; Peter J Sabo; Rajinder Kaul; Terrence S Furey; Job Dekker; Gregory E Crawford; John A Stamatoyannopoulos
Journal:  Nature       Date:  2012-09-06       Impact factor: 49.962

View more
  4 in total

1.  Autonomous actions of the human growth hormone long-range enhancer.

Authors:  Eung Jae Yoo; Christopher D Brown; Yu-Cheng Tsai; Nancy E Cooke; Stephen A Liebhaber
Journal:  Nucleic Acids Res       Date:  2015-02-06       Impact factor: 16.971

2.  An unusual intragenic promoter of PIWIL2 contributes to aberrant activation of oncogenic PL2L60.

Authors:  Shan-Shan Liu; Ning Liu; Meng-Yao Liu; Lei Sun; Wu-Yan Xia; Hong-Min Lu; Yu-Jie Fu; Guo-Liang Yang; Juan-Jie Bo; Xiao-Xing Liu; Haizhong Feng; Hailong Wu; Lin-Feng Li; Jian-Xin Gao
Journal:  Oncotarget       Date:  2017-07-11

3.  Identification of a secondary promoter of CASP8 and its related transcription factor PURα.

Authors:  Zhengwei Lin; Zhimin Guo; Yang Xu; Xiaohang Zhao
Journal:  Int J Oncol       Date:  2014-05-09       Impact factor: 5.650

Review 4.  Exploring 3D chromatin contacts in gene regulation: The evolution of approaches for the identification of functional enhancer-promoter interaction.

Authors:  Hang Xu; Shijie Zhang; Xianfu Yi; Dariusz Plewczynski; Mulin Jun Li
Journal:  Comput Struct Biotechnol J       Date:  2020-02-28       Impact factor: 7.271

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.